Company news

Lumos Diagnostics Holdings Ltd. news in 2024

Lumos Diagnostics Holdings Ltd.'s news releases, calls and decks from 2024, newest first.

View company

Commencement of FebriDx CLIA Waiver Study

December 19, 2024

Lumos receives CPT PLA Code for FebriDX in the US

December 4, 2024

Lumos Successfully Completes Retail Entitlement Offer

October 7, 2024

Lumos and BARDA Partner to Support FebriDx CLIA Waiver Study

October 2, 2024

Lumos Awarded National Contract with MediGroup for FebriDx

September 25, 2024

Lumos Achieves First Phase 2 Milestone in Hologic Agreement

September 20, 2024

Lumos Appoints Thermo Fisher Scientific as US Distributor

September 15, 2024

Retail Entitlement Offer Booklet

September 10, 2024

Lumos Successfully Completes Institutional Entitlement Offer

September 5, 2024

Lumos Announces $10m Equity Raising and Welcomes Tenmile

September 4, 2024

Lumos Announces Intention to Undertake Entitlement Offer

September 3, 2024

FY24 Full Year Results Announcement

August 26, 2024

FY24 Appendix 4E

August 26, 2024

Lumos and BDI Progress New Point of Care Test

August 25, 2024

Lumos Expands Henry Schein FebriDx Distribution Partnership

July 8, 2024

Lumos Expands Distribution for FebriDx in AUS and NZ

July 3, 2024

Lumos Receives Second US$5 million Hologic IP Payment

June 3, 2024

Lumos Achieves Key Phase 1 Milestone in Hologic Agreement

May 5, 2024

Half Year Results Investor Presentation

February 27, 2024

Lumos Appoints Henry Schein as US Distributor for FebriDx

February 11, 2024

Lumos Signs Major Development and IP Agreements with Hologic

January 10, 2024

Decks in 2024